NOMURA ASSET MANAGEMENT CO LTD
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1055964
TOKYO, M0
Position in AMRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$934,359
+$263,413 QoQ
Shares Held
53,978
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#139
of 305 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT CO LTD holds $72,048,993 across 11 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
525,329 | $37,750,141 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
384,707 | $13,033,873 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
18,237 | $9,881,352 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
56,651 | $9,547,959 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
53,978 | $934,359 | |
| 6 | VTRS |
Viatris Inc
|
48,580 | $771,450 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
2,860 | $70,384 | |
| 8 | PRGO |
PERRIGO Co plc
|
2,900 | $30,131 |
All Filings in AMRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $934,359 | 53,978 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $670,946 | 53,978 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $680,122 | 53,978 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $540,319 | 53,978 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $436,682 | 53,978 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||